The DNAAF9 gene helps build the tiny moving hairs called cilia that clear mucus from the airways and support normal movement in parts of the body such as the sinuses and reproductive tract. If the DNAAF9 gene does not work properly, cilia may not beat well, so some people develop primary ciliary dyskinesia, with ongoing cough, repeated chest or sinus infections, and ear problems. Some may also have fertility problems or organs that developed in an unusual left-right pattern.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes hold the information needed to make proteins, the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. To go into this topic in more detail, you can find more in the LearnHub.
Overview
DNAAF9Gene function
What if the gene works
The DNAAF9 gene helps cells build the motor parts of motile cilia, the tiny hairs that beat on certain surfaces. This supports normal mucus clearance in the airways and fluid movement in places like the sinuses and reproductive tract.
Risk
What if the gene does not work
More disruptive variants in the DNAAF9 gene can cause primary ciliary dyskinesia, where airway cilia do not move well. This often leads to wet cough, sinus and chest infections, and fertility problems; symptoms can range from mild to more pronounced.
Treatment
What does that mean for your treatment
No DNAAF9-specific treatment or management approach is currently established; care is based on the person’s symptoms and clinical findings rather than the particular DNAAF9 variant.
Gene function
What if the gene works
The DNAAF9 gene helps your cells build the motor parts that let motile cilia beat. Motile cilia are tiny hair-like structures that move mucus in the airways and help shift fluid in places such as the brain and reproductive tract. When this gene works normally, those movements stay organized and efficient.
The DNAAF9 gene helps cells put together dynein arms, the motor units that drive cilia movement. This preparation happens before the motor parts are placed into the cilia.
Inside your cells, DNAAF9 works with other helper proteins to fold and stabilize cilia motor pieces. This helps those parts reach the cilia in a form that can work smoothly.
By supporting motile cilia function, the DNAAF9 gene helps cilia beat in a steady, repeated rhythm. This everyday action helps clear mucus from the airways and move fluid where your body needs it.
What is a variant?
A genetic variant is a slight difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the DNAAF9 gene can reduce or disrupt assembly of the motor parts that let cilia, the tiny hairlike structures lining the airways and reproductive tract, move in a coordinated way. This is central to how DNAAF9 gene variants affect cilia function. Milder variants may leave some protein activity, while more severe variants can result in little or no working protein, often leading to greater cilia dysfunction and, in primary ciliary dyskinesia, earlier or more noticeable features.
How variants are linked to conditions
Pathogenic variants in the DNAAF9 gene cause a form of primary ciliary dyskinesia, an inherited condition linked to long lasting chest infections, chronic nasal congestion, repeated ear problems, and sometimes reduced fertility. Some people also have organ placement differences such as situs inversus. In short, DNAAF9 gene variants linked to primary ciliary dyskinesia can confirm the diagnosis when a disease causing variant is found.
A variant is not necessarily a diagnosis
Genetic variants are a common and expected part of human biology in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. In many genes, carrying a variant tied to a condition suggests a possible association rather than a certain diagnosis, especially when several genes and environmental factors play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For DNAAF9, risk is mainly tied to whether someone is born with harmful changes in both copies of the gene, and there is not broadly confirmed evidence that lifestyle or environmental factors meaningfully change that risk. Anyone with questions about personal or family risk can talk with a doctor or genetic counselor.
Inheritance of DNAAF9 variants
DNAAF9-related primary ciliary dyskinesia is inherited in an autosomal recessive pattern. This means a person usually develops the condition only if they inherit two disease-causing variants in the DNAAF9 gene, one from each parent. Parents who each carry one variant are typically unaffected carriers. With each pregnancy, two carrier parents have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child without either variant.
What does my DNAAF9 result mean for my family?
For families with a disease-causing change in the DNAAF9 gene, the pattern is usually recessive, which means parents are often healthy carriers. Brothers and sisters may also have the condition or be carriers, so they may want to talk with their care team about whether testing would be helpful. More distant relatives can sometimes be carriers too, especially on the parent’s side where the gene change came from.
Genetic information
Genetic testing
How you find out about variants
If your care team is considering genetic testing for DNAAF9 variants, the lab usually uses a blood sample or cheek swab to read the DNA code in the DNAAF9 gene. The results can show whether you carry a variant linked to a genetic condition, are a carrier, or have no relevant change detected.
When should I consider getting a genetic test?
Consider testing for changes in the DNAAF9 gene if you or your child has signs of a rare condition that affects the body’s tiny airway hairs, such as a daily wet cough from early childhood, repeated sinus or chest infections, or organs that developed on the opposite side. Testing may also make sense if this condition runs in the family or a relative has a known DNAAF9 change.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains varies based on the condition and the kind of variant involved. Over time, many factors also affect how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information offers context more than certainty and is best considered together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds at the drug’s target, so the same treatment may work better for one person than for another. This is a common reason why some people get less benefit, while others are more sensitive to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. By studying links between genes and drugs, it helps clarify why the same treatment may work differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body processes it. This information can support more informed, more individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the DNAAF9 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how people respond to medicines, so general medication questions or health concerns are best discussed with your doctor. Seek medical advice if you have new side effects, your treatment does not seem to be helping, or you are unsure how your medicines fit with your overall health.
History
In recent decades, awareness of this gene’s role has grown. DNAAF9 first appeared in research under the more generic name C20orf194, before later studies connected it to the body’s tiny moving cilia and led to the current name, the DNAAF9 gene. From these first observations, research expanded steadily. A key step came when variants in the DNAAF9 gene were linked to primary ciliary dyskinesia, a condition that affects cilia movement and can run in families. That discovery helped place DNAAF9 among a growing group of genes involved in cilia-related conditions. Over time, descriptions became more precise as genetic testing and cilia research improved.